ProQR Therapeutics N.V.

NASDAQ:PRQR

1.69 (USD) • At close March 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019201820172016201520142013
Revenue 18.9056.5144.0371.35401.9334.941-1.5292.2829.4070.3130
Cost of Revenue 00.1342.47602.194116.8230.9841.0011.2820.48300
Gross Profit 18.9056.381.5611.354-2.194-114.893.957-2.5318.9240.3130
Gross Profit Ratio 10.980.38710-59.4360.8011.6550.4380.94910
Reseach & Development Expenses 36.35625.14850.86742.2238.13546.49129.51431.15331.92323.40110.2672.569
General & Administrative Expenses 13.66116.23618.65117.36813.68512.88712.5410.849.4786.8376.5070.786
Selling & Marketing Expenses 000000000000
SG&A 13.66116.23618.65117.36813.68512.88712.5410.849.4786.8376.5070.786
Other Expenses -0.64-3.011-0.765-1.0439.3681.9335.7611.4951.8283.2350.3130
Operating Expenses 49.37738.37368.75358.54551.8259.37842.05441.99341.40130.23816.7743.239
Operating Income -30.472-31.859-64.716-57.191-42.368-57.445-36.293-40.498-39.573-27.003-16.461-3.239
Operating Income Ratio -1.612-4.891-16.031-42.2390-29.718-7.34526.487-17.341-2.871-52.5910
Total Other Income Expenses Net 2.5124.0461.051-3.472-4.122117.654-0.7920.850.476.1714.334-0.014
Income Before Tax -27.96-27.813-64.795-61.563-46.49-56.614-37.085-43.673-39.103-20.832-12.127-3.253
Income Before Tax Ratio -1.479-4.27-16.05-45.4680-29.288-7.50628.563-17.135-2.215-38.7440
Income Tax Expense -0.197-0.0780.0960.1170.1240.1320.0010.002-0.47-6.171-4.3340.024
Net Income -27.763-28.119-64.891-61.68-46.614-56.746-36.894-43.637-39.103-20.832-12.127-3.253
Net Income Ratio -1.469-4.317-16.074-45.5540-29.356-7.46728.54-17.135-2.215-38.7440
EPS 0-0.35-0.91-0.96-0.93-1.38-1.08-1.72-1.67-0.89-1.09-0.15
EPS Diluted 0-0.35-0.91-0.96-0.93-1.38-1.08-1.72-1.67-0.89-1.09-0.15
EBITDA -24.122-24.097-56.46-54.948-136.556-174.268-35.2910-120.547-84.244-49.696-3.191
EBITDA Ratio -1.276-3.699-14.71-40.8980-29.656-8.3126.768-17.597-3.163-53.1880